Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

M. Saito, Daisuke Aoki, N. Susumu, A. Suzuki, N. Suzuki, Y. Udagawa, S. Nozawa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two tumor markers can be detected by a combination immunoenzymometric assay of these two antigens. This combination assay was initially performed in 1189 patients with clinically detected ovarian tumors (final pathological diagnosis: 645 cases of benign disease and 544 cases of malignant disease), and benign disease included 122 patients with endometriosis and 523 normal healthy women. The combination of CA602 and CA546 increased the detection rate of ovarian cancer from 77.8 to 85.8% compared with CA602 alone, demonstrating that the combination assay was effective at detecting ovarian cancers. The combination assay of CA602 and CA546 was then applied to 21,374 random subjects to screen for asymptomatic ovarian cancer. Ovarian cancer was detected in nine patients (detection rate: 0.04%), of which four cases were stage 1 disease. A retrospective analysis of these four patients revealed that a screening based on only a single assay would have been negative and further reiterates the effectiveness of this combination assay in detecting potential disease.

Original languageEnglish
Pages (from-to)37-44
Number of pages8
JournalInternational Journal of Gynecological Cancer
Volume15
Issue number1
DOIs
Publication statusPublished - 2005 Jan

Fingerprint

Tumor Biomarkers
Ovarian Neoplasms
Endometriosis
CA602 antigen
Antigens
Neoplasms

Keywords

  • CA546
  • CA602
  • Combination assay
  • Ovarian cancer
  • Screening

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology
  • Cancer Research

Cite this

Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546. / Saito, M.; Aoki, Daisuke; Susumu, N.; Suzuki, A.; Suzuki, N.; Udagawa, Y.; Nozawa, S.

In: International Journal of Gynecological Cancer, Vol. 15, No. 1, 01.2005, p. 37-44.

Research output: Contribution to journalArticle

Saito, M. ; Aoki, Daisuke ; Susumu, N. ; Suzuki, A. ; Suzuki, N. ; Udagawa, Y. ; Nozawa, S. / Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546. In: International Journal of Gynecological Cancer. 2005 ; Vol. 15, No. 1. pp. 37-44.
@article{aae9c981f113411fa3dc40c604e5241b,
title = "Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546",
abstract = "A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two tumor markers can be detected by a combination immunoenzymometric assay of these two antigens. This combination assay was initially performed in 1189 patients with clinically detected ovarian tumors (final pathological diagnosis: 645 cases of benign disease and 544 cases of malignant disease), and benign disease included 122 patients with endometriosis and 523 normal healthy women. The combination of CA602 and CA546 increased the detection rate of ovarian cancer from 77.8 to 85.8{\%} compared with CA602 alone, demonstrating that the combination assay was effective at detecting ovarian cancers. The combination assay of CA602 and CA546 was then applied to 21,374 random subjects to screen for asymptomatic ovarian cancer. Ovarian cancer was detected in nine patients (detection rate: 0.04{\%}), of which four cases were stage 1 disease. A retrospective analysis of these four patients revealed that a screening based on only a single assay would have been negative and further reiterates the effectiveness of this combination assay in detecting potential disease.",
keywords = "CA546, CA602, Combination assay, Ovarian cancer, Screening",
author = "M. Saito and Daisuke Aoki and N. Susumu and A. Suzuki and N. Suzuki and Y. Udagawa and S. Nozawa",
year = "2005",
month = "1",
doi = "10.1111/j.1048-891X.2005.15004.x",
language = "English",
volume = "15",
pages = "37--44",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546

AU - Saito, M.

AU - Aoki, Daisuke

AU - Susumu, N.

AU - Suzuki, A.

AU - Suzuki, N.

AU - Udagawa, Y.

AU - Nozawa, S.

PY - 2005/1

Y1 - 2005/1

N2 - A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two tumor markers can be detected by a combination immunoenzymometric assay of these two antigens. This combination assay was initially performed in 1189 patients with clinically detected ovarian tumors (final pathological diagnosis: 645 cases of benign disease and 544 cases of malignant disease), and benign disease included 122 patients with endometriosis and 523 normal healthy women. The combination of CA602 and CA546 increased the detection rate of ovarian cancer from 77.8 to 85.8% compared with CA602 alone, demonstrating that the combination assay was effective at detecting ovarian cancers. The combination assay of CA602 and CA546 was then applied to 21,374 random subjects to screen for asymptomatic ovarian cancer. Ovarian cancer was detected in nine patients (detection rate: 0.04%), of which four cases were stage 1 disease. A retrospective analysis of these four patients revealed that a screening based on only a single assay would have been negative and further reiterates the effectiveness of this combination assay in detecting potential disease.

AB - A new efficient screening for ovarian cancer based on a combination of two tumor markers, CA602 and CA546, is reported. These two tumor markers can be detected by a combination immunoenzymometric assay of these two antigens. This combination assay was initially performed in 1189 patients with clinically detected ovarian tumors (final pathological diagnosis: 645 cases of benign disease and 544 cases of malignant disease), and benign disease included 122 patients with endometriosis and 523 normal healthy women. The combination of CA602 and CA546 increased the detection rate of ovarian cancer from 77.8 to 85.8% compared with CA602 alone, demonstrating that the combination assay was effective at detecting ovarian cancers. The combination assay of CA602 and CA546 was then applied to 21,374 random subjects to screen for asymptomatic ovarian cancer. Ovarian cancer was detected in nine patients (detection rate: 0.04%), of which four cases were stage 1 disease. A retrospective analysis of these four patients revealed that a screening based on only a single assay would have been negative and further reiterates the effectiveness of this combination assay in detecting potential disease.

KW - CA546

KW - CA602

KW - Combination assay

KW - Ovarian cancer

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=13244266978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244266978&partnerID=8YFLogxK

U2 - 10.1111/j.1048-891X.2005.15004.x

DO - 10.1111/j.1048-891X.2005.15004.x

M3 - Article

C2 - 15670295

AN - SCOPUS:13244266978

VL - 15

SP - 37

EP - 44

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 1

ER -